Search results
Tuesday briefing: Columbia University student protest; Charlotte shooting; Trump trial;...
Washington Post· 1 day agoCatch up in minutes with these 7 stories.
Sage Therapeutics (SAGE) Q1 Earnings Miss, Sales Beat Estimates
Zacks via Yahoo Finance· 5 days agoSage Therapeutics' (SAGE) first-quarter 2024 results are mixed as earnings miss estimates, but sales...
Sage Therapeutics Inc (SAGE) Q1 2024 Earnings: Mixed Results Amidst Pipeline Progress
GuruFocus.com via Yahoo Finance· 6 days agoFocusing on depression, neurology, and neuropsychiatry, Sage targets the central nervous system's GABA and NMDA receptor systems. Its notable products include ZURZUVAE for ...
EEOC Finalizes Pregnant Workers Fairness Act – and States are Challenging It
The National Law Review· 2 days agoOn April 15, the Equal Employment Opportunity Commission (EEOC) issued its long-awaited final rule...
EEOC Issues Final Rule Maintaining Agency’s Expansive Interpretation of Pregnant Workers Fairness...
JD Supra· 1 day agoThe Pregnant Workers Fairness Act (PWFA) was enacted in 2023 to protect pregnant employees from workplace discrimination and ensure they receive reasonable accommodations in the workplace. On ...
Biogen Stock Surges After Two Notable Products Walloped Sales Expectations
Investor's Business Daily· 7 days ago"We believe this helps reassure that the long-term (return on investment) for the Reata acquisition...
Q2 2024 EPS Estimates for Sage Therapeutics, Inc. Cut by William Blair (NASDAQ:SAGE)
ETF DAILY NEWS· 2 days agoSage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) – Research analysts at William Blair decreased their Q2 2024 EPS estimates for shares of Sage Therapeutics in a research note issued on Thursday ...
EEOC Issues Final Regulations to the Pregnant Workers Fairness Act (PWFA): Key Takeaways | JD Supra
JD Supra· 5 days ago...for accommodation” under the PWFA include current pregnancy, past pregnancy, potential pregnancy, lactation (including breastfeeding and pumping), use of birth control, menstruation, migraines, pregnancy-related conditions that are episodic-like morning sickness, postpartum depression,...
‘A Body Made of Glass’ Review: Hypochondria and Humanity
The Wall Street Journal· 5 days agoHow many women have been ignored for conditions like polycystic ovary syndrome, painful menstruation...
Mizuho Cuts Sage Therapeutics (NASDAQ:SAGE) Price Target to $18.00
ETF DAILY NEWS· 2 days agoSage Therapeutics (NASDAQ:SAGE – Free Report) had its price target lowered by Mizuho from $20.00 to $18.00 in a report published on Friday, Benzinga reports. The brokerage currently has a neutral ...